Larson Financial Group LLC Has $199,000 Position in Waters Co. (NYSE:WAT)

Larson Financial Group LLC increased its position in Waters Co. (NYSE:WAT) by 6.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 537 shares of the medical instruments supplier’s stock after buying an additional 34 shares during the quarter. Larson Financial Group LLC’s holdings in Waters were worth $199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Arjuna Capital acquired a new position in shares of Waters in the fourth quarter valued at approximately $447,000. PNC Financial Services Group Inc. boosted its holdings in Waters by 29.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 22,041 shares of the medical instruments supplier’s stock valued at $8,177,000 after acquiring an additional 4,983 shares during the last quarter. Callan Family Office LLC bought a new stake in Waters in the fourth quarter valued at approximately $305,000. E Fund Management Co. Ltd. boosted its holdings in Waters by 56.1% in the fourth quarter. E Fund Management Co. Ltd. now owns 996 shares of the medical instruments supplier’s stock valued at $369,000 after acquiring an additional 358 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Waters in the fourth quarter valued at approximately $40,404,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on WAT. Bank of America reduced their target price on Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a report on Thursday, February 13th. JPMorgan Chase & Co. upped their target price on Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a report on Thursday, March 6th. Barclays upgraded Waters from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $360.00 to $415.00 in a report on Monday, February 10th. Wells Fargo & Company upped their target price on Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Finally, StockNews.com cut Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Eleven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $391.07.

Waters Price Performance

Shares of WAT opened at $378.04 on Wednesday. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The business’s fifty day moving average is $391.16 and its 200 day moving average is $369.78. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The stock has a market cap of $22.46 billion, a P/E ratio of 35.30, a P/E/G ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Sell-side analysts anticipate that Waters Co. will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.